BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38646081)

  • 1. A case of cardiogenic shock due to ventricular dyssynchrony resolved by atrial pacing.
    Chakrala TS; Prakash RO; Prasada S; Rigger WR; Vilaro J
    J Cardiol Cases; 2024 Apr; 29(4):149-152. PubMed ID: 38646081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporary coronary sinus pacing to improve ventricular dyssynchrony with cardiogenic shock: A case report.
    Ju TR; Tseng H; Lin HT; Wang AL; Lee CC; Lai YC
    World J Clin Cases; 2021 Jul; 9(20):5562-5567. PubMed ID: 34307610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.
    Wilkoff BL;
    Card Electrophysiol Rev; 2003 Dec; 7(4):468-72. PubMed ID: 15071277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk Stratification of Future Left Ventricular Dysfunction for Patients with Indications for Right Ventricular Pacing due to Bradycardia.
    Ooka J; Tanaka H; Hatani Y; Hatazawa K; Matsuzoe H; Shimoura H; Sano H; Sawa T; Motoji Y; Mochizuki Y; Ryo-Koriyama K; Matsumoto K; Fukuzawa K; Hirata KI
    Int Heart J; 2017 Oct; 58(5):724-730. PubMed ID: 28966312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biventricular pacing (cardiac resynchronization therapy): an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(13):1-60. PubMed ID: 23074464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Right ventricular pacing is an independent predictor for ventricular tachycardia/ventricular fibrillation occurrence and heart failure events in patients with an implantable cardioverter-defibrillator.
    Gardiwal A; Yu H; Oswald H; Luesebrink U; Ludwig A; Pichlmaier AM; Drexler H; Klein G
    Europace; 2008 Mar; 10(3):358-63. PubMed ID: 18308756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The importance of avoiding unnecessary right ventricular pacing in clinical practice.
    Akerström F; Arias MA; Pachón M; Jiménez-López J; Puchol A; Juliá-Calvo J
    World J Cardiol; 2013 Nov; 5(11):410-9. PubMed ID: 24340139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-tachycardia pacing degenerated fast ventricular tachycardia into undetectable life-threatening tachyarrhythmia in a patient with non-ischemic dilated cardiomyopathy.
    Yunoki K; Nishii N; Morita H; Iwasaki J; Nagase S; Nakamura K; Hata Y; Kohno K; Kusano KF; Ito H
    J Cardiol Cases; 2010 Dec; 2(3):e159-e162. PubMed ID: 30546708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iatrogenic pacemaker-induced ventricular arrhythmia: a case report.
    Pooranachandran V; Hodson T; Nicolson W; Ng GA
    Eur Heart J Case Rep; 2022 May; 6(5):ytac189. PubMed ID: 35592746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse effects of long-term right ventricular apical pacing and identification of patients at risk of atrial fibrillation and heart failure.
    De Sisti A; Márquez MF; Tonet J; Bonny A; Frank R; Hidden-Lucet F
    Pacing Clin Electrophysiol; 2012 Aug; 35(8):1035-43. PubMed ID: 22452247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of right ventricular lead position on left ventricular functions and early remodeling in permanent single- and dual-chamber pacemakers.
    Ali AN; Hawas AN; Ramadan AY; Tamara AF
    Herzschrittmacherther Elektrophysiol; 2022 Dec; 33(4):432-439. PubMed ID: 36129537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced risk for inappropriate implantable cardioverter-defibrillator shocks with dual-chamber therapy compared with single-chamber therapy: results of the randomized OPTION study.
    Kolb C; Sturmer M; Sick P; Reif S; Davy JM; Molon G; Schwab JO; Mantovani G; Dan D; Lennerz C; Borri-Brunetto A; Babuty D
    JACC Heart Fail; 2014 Dec; 2(6):611-9. PubMed ID: 25282033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indications for dual-chamber (DDD) pacing in implantable cardioverter-defibrillator patients.
    Santini M; Ansalone G; Auriti A; Magris B; Pandozi C; Altamura G
    Am J Cardiol; 1996 Sep; 78(5A):116-8. PubMed ID: 8820847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Speckle-tracking echocardiography elucidates the effect of pacing site on left ventricular synchronization in the normal and infarcted rat myocardium.
    Mor M; Mulla W; Elyagon S; Gabay H; Dror S; Etzion Y; Liel-Cohen N
    PLoS One; 2014; 9(6):e99191. PubMed ID: 24915191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic right ventricular apical pacing: adverse effects and current therapeutic strategies to minimize them.
    Akerström F; Pachón M; Puchol A; Jiménez-López J; Segovia D; Rodríguez-Padial L; Arias MA
    Int J Cardiol; 2014 May; 173(3):351-60. PubMed ID: 24721486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of supraventricular tachycardia misdiagnosis after dual-chamber implantable cardioverter defibrillator implantation with His bundle pacing.
    Sun X; Huang Y
    Ann Noninvasive Electrocardiol; 2023 May; 28(3):e13042. PubMed ID: 36639840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marked attenuation of shock burden by the use of antitachycardia pacing therapy in a patient with an implanted cardioverter-defibrillator.
    Ganjehei L; Nazeri A; Massumi A; Razavi M
    Tex Heart Inst J; 2012; 39(4):568-70. PubMed ID: 22949781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postpacing Interval During Right Ventricular Overdrive Pacing to Discriminate Supraventricular from Ventricular tachycardia.
    Yalin K; Golcuk E; Karaayvaz EB; Aksu T; Arslane M; Tiryakioglu SK; Bilge AK; Adalet K
    J Atr Fibrillation; 2017; 10(2):1619. PubMed ID: 29250234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A unique case report of relapsing eosinophilic myocarditis causing atrial myopathy and persistent sinus arrest.
    Huynh R; Sy RW; Wong SJ; Wong CCY
    Eur Heart J Case Rep; 2022 Feb; 6(2):ytac047. PubMed ID: 35233495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation of sinus tachycardia from ventricular tachycardia with 1:1 ventriculoatrial conduction in dual chamber implantable cardioverter defibrillators: feasibility of a criterion based on the atrioventricular interval.
    LeCarpentier GL; Baga JJ; Yang H; Steinman RT; Meissner MD; Lehmann MH
    Pacing Clin Electrophysiol; 1994 Nov; 17(11 Pt 1):1818-31. PubMed ID: 7838794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.